Organizations Tell USPTO Proposed 2025 Fees ‘Misuse’ Office’s Fee Setting Authority
IP Watchdog
JUNE 5, 2024
Patent and Trademark Office’s (USPTO’s) proposed fee schedule for 2025 to express their concern about certain substantial fee increases.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
IP Watchdog
JUNE 5, 2024
Patent and Trademark Office’s (USPTO’s) proposed fee schedule for 2025 to express their concern about certain substantial fee increases.
IP Watchdog
MARCH 25, 2024
After a year-long process involving 38 state organizations and dozens of individual representatives, IP rights has been selected as the topic for the 2024-2025 debate competition by The National Federation of State High School Associations (NFHS). Should the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Technology & Marketing Law Blog
APRIL 3, 2024
The conference will be hosted by the High Tech Law Institute and held at Santa Clara University School of Law on March 8, 2025. The post SAVE THE DATE: Internet Law Works-in-Progress Conference, SCU, March 8, 2025 appeared first on Technology & Marketing Law Blog. We can’t wait to see you in person!
JD Supra Law
APRIL 11, 2024
The United States Patent and Trademark Office (USPTO) has proposed significant changes to patent fee structures for the 2025 fiscal year. These proposed changes mark a pivotal shift in the Office’s financial approach toward patent filings. By: Seyfarth Shaw LLP
JD Supra Law
MARCH 4, 2024
As independent schools embark on the 2024-2025 school year, it is imperative that they ensure that their employee and student handbooks are not only comprehensive but also address new and evolving issues affecting independent schools.
JD Supra Law
FEBRUARY 20, 2024
Patent and Trademark Office (USPTO) is going to implement fee changes in January 2025, we should see a Federal Register Notice detailing the proposed fees soon. If the U.S.
JD Supra Law
APRIL 4, 2024
The USPTO has taken another step towards implementing fee adjustments in January 2025, by publishing a Notice of Proposed Rulemaking (RPRM) on April 3, 2024. The NPRM stands by most of the significant fee adjustments it proposed in April 2023, with a few changes made in response to input from the Patent Public Advisory Committee (PPAC).
JD Supra Law
APRIL 23, 2024
Heading into 2025, patent applicants should prepare for significant fee increases at the United States Patent and Trademark Office (USPTO). These fee increases can significantly impact patent applicant behavior, leading prudent applicants to evaluate and adjust their patent protection strategies.
The TTABlog
MARCH 26, 2024
The USPTO is proposing to increase many trademark fees in Fiscal Year 2025. The proposal is set forth in a Notice of Proposed Rulemaking to be published today (pdf here ). Comments are due by May 28th. trademark system.
LexBlog IP
SEPTEMBER 14, 2023
The bill goes into effect on January 1, 2025, and a public outreach effort will begin by July 1, 2024. This week, Delaware Governor John Carney signed the Delaware Personal Data Privacy Act into law. The outreach effort will inform Delaware consumers of their rights under the new law and describe businesses’ obligations.
JD Supra Law
APRIL 25, 2023
The USPTO has commenced the fee-setting process for fee adjustments it expects to implement in January 2025. By: Foley & Lardner LLP
The TTABlog
APRIL 11, 2024
Marty Schwimmer and yours truly, the TTABlogger , have decided to postpone our next MEET THE BLOGGERS get-together until next year. For some reason, I think it will be in Philadelphia. Does that ring a bell? In any event, we hope to see y'all in Atlanta next month.
Canadian Intellectual Property Blog
SEPTEMBER 21, 2023
If you sell products or have public signage in the Province of Québec, then please consider what changes, if any, will be necessary to the product inscriptions/packaging and signage to ensure compliance with the amendments to the Charter of the French Language, c-11, which will come into force on June 1, 2025.
IP Close Up
APRIL 9, 2024
Thanks in part to data-hungry artificial intelligence and growing anger over foreign and domestic intellectual property abuses, fixing the IP system is more topical than Continue reading
JD Supra Law
MAY 30, 2024
This webinar will cover: 2024/2025 patent litigation trends: ITC domestic industry, double patenting, forum shopping, legislative proposals, and more. Will the 2025 PTAB look like the 2024 PTAB? Pulling it all together to mange parallel proceedings in 2025 and beyond. Rule proposals – what makes it? Legislation?
JD Supra Law
MAY 30, 2024
This webinar will cover: 2024/2025 patent litigation trends: ITC domestic industry, double patenting, forum shopping, legislative proposals, and more. Will the 2025 PTAB look like the 2024 PTAB? Pulling it all together to mange parallel proceedings in 2025 and beyond. Rule proposals – what makes it? Legislation?
McKinsey Operations
JULY 8, 2022
What will drive China’s next wave of cloud adoption? Successful enterprises will focus not on moving to the cloud but on using it to deliver tangible business value.
JD Supra Law
JUNE 13, 2024
During a recent meeting, the Canadian Intellectual Property Office (CIPO) revealed plans for a significant reduction in the first examination of Canadian trademark applications not using the pre-approved list of goods and services from 54 months to 24 months by March 2025. This announcement follows CIPO’s recent hiring of 160 new examiners.
The Illusion of More
MAY 24, 2024
Yesterday, the House Energy & Commerce Committee held a hearing to discuss draft legislation that would sunset Section 230 of the Communications Decency Act on December 31, 2025. If passed, the law would start a countdown toward abolishing Section 230 with the real intent to force Big Tech to cooperate on meaningful reform.
JD Supra Law
MAY 29, 2024
Patent and Trademark Office’s (USPTO’s) proposed rulemaking that focuses on “fee adjustments” for 2025 includes a trap for the unwary related to Information Disclosure Statements (IDSs) that could complicate compliance with the Duty of Disclosure.
JD Supra Law
OCTOBER 23, 2023
By 2025, various online sources estimate. Slack, a collaboration tool for workplaces, has been among the forces upending the established communication order, offering an organized alternative to email. By: Array
JD Supra Law
OCTOBER 25, 2023
In 2025, the National Aeronautics and Space Administration (NASA) is scheduled to once again bring man and machine to the lunar surface, this time under the name of the Greek goddess Artemis. However, the means to the ends have changed.
LexBlog IP
DECEMBER 13, 2023
Samsung Bioepis recently reported that it has signed a settlement and license agreement with Johnson & Johnson (“J&J”) in the United States relating to SB17, Samsung Bioepis’s ustekinumab biosimilar to J&J’s STELARA® If SB17 is approved by the FDA, the license period in the United States will begin on February (..)
JD Supra Law
JULY 24, 2023
Established through the Charter of the French Language, French is the official language of the Province of Québec. The Charter applies to businesses located in Québec and to other businesses providing services and selling goods in this province, making the use of French mandatory in connection with these business activities.
JD Supra Law
FEBRUARY 15, 2024
Bayer has a second patent that is subject to a pediatric exclusivity that expires later - February 2025 - and Mylan concedes that the second patent blocks approval for its generic version of Xarelto® until that time. Bayer's ‘053 patent on its drug Xarelto® expires in November 2024, and Bayer granted Mylan a covenant not to sue.
JD Supra Law
MARCH 7, 2024
by February 2025, subject to FDA approval. The parties announced in a press release that their settlement and license agreement allows Biocon to commercialize Bmab 1200, its proposed biosimilar to Stelara® (ustekinumab), in the U.S. By: Venable LLP
JD Supra Law
MARCH 28, 2022
It is estimated that by 2025, more than 26 billion home and workplace devices will be connected to the internet and have embedded software or sensors. The economic impact of these “connected” devices is estimated to be approximately $10 trillion per year by 2025. It is no surprise then that in the last.
LexBlog IP
FEBRUARY 7, 2024
Amendments to the Charter are expected to come into force on June 1, 2025. As of June 1, 2025, unless a trademark appearing on a product, on a storefront or in commercial advertising is registered in Canada, a French version of that mark will have to appear. Fines for second offences are doubled and thereafter tripled.
Michael Geist
AUGUST 25, 2023
The proposed timeline has taken many by surprise as it suggests that mandatory bargaining may not begin until 2025. Certifying “eligible news businesses” and confirming arbitrators could take the process into early 2025, at which time the mandatory bargaining process can begin.
JD Supra Law
DECEMBER 13, 2023
If SB17 is approved by the FDA, the license period in the United States will begin on February 22, 2025. Samsung Bioepis recently reported that it has signed a settlement and license agreement with Johnson & Johnson (“J&J”) in the United States relating to SB17, Samsung Bioepis’s ustekinumab biosimilar to J&J’s STELARA®.
JD Supra Law
MARCH 25, 2024
Goldman Sachs reported AI investment was forecast to approach $200 billion globally by 2025, and 47% of top technology officers (e.g. What began as cocktail hour conversations and funny experiments quickly made its way into boardrooms and budgets. CIO, CTO) reported to CNBC that AI was their number one budget item in 2024.
Stock Legal Blog
JUNE 4, 2024
By coding, running, and analyzing my own study, I will assess both the presumed and actual reliability of earwitness testimony as it relates to the criminal-legal system—eventually graduating with honors from the College of Arts and Sciences in the Spring of 2025.
Olartemoure Blog
FEBRUARY 8, 2024
This year, it begins on February 10th 2024 , and finishes on 29th of January 2025 , marking the start of the Year of the Snake. Variable dates of the chinese new year: The start of the Chinese New Year varies each year due to its adherence to the lunar calendar.
JD Supra Law
JANUARY 18, 2024
Amendments to the Charter of French Language (Charter) scheduled to come into force on June 1, 2025 will have major implications on trademark owners doing business in Quebec, Canada. This doesn’t just impact Canadian companies, but also the many U.S. companies doing business in Canada.
JD Supra Law
FEBRUARY 19, 2024
For example, it is estimated that by 2025, more than 26 billion home and workplace devices will be connected to the Internet and have sensors, processors, and embedded software for facilitating connectivity. By: Sterne, Kessler, Goldstein & Fox P.L.L.C.
JD Supra Law
AUGUST 31, 2023
market on March 7, 2025, if approved by FDA. It has been reported that Celltrion has finalized a settlement with Johnson & Johnson (“J&J”) in the United States relating to CT-P43, Celltrion’s ustekinumab biosimilar to J&J’s STELARA®, which would permit Celltrion to launch the product in the U.S. By: Goodwin
The IP Law Blog
MARCH 5, 2024
Deadlines to File Your BOI Report: Entity Type BOI Filing Deadline Entities in Existence Prior to January 1, 2024 On or before January 1, 2025 Entities Formed on or after January 1, 2024 90 days from the date of formation Entities Formed on or after January 1, 2025 30 days from the date of formation Resources: Corporate Transparency Act Resource Hub (..)
IP Law 360
APRIL 26, 2023
Patent and Trademark Office has proposed numerous patent fee increases that would take effect in 2025 if adopted, including notable hikes related to continuing applications, design patents and post-grant challenges that attorneys say could alter applicant behavior.
LexBlog IP
JUNE 13, 2023
. “According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025.” The post Alvotech and Teva Reach Ustekinumab (STELARA) Settlement with J&J appeared first on Big Molecule Watch.
Indiana Intellectual Property Law
JULY 1, 2024
Collins has announced her plans to retire in July 2025, culminating a distinguished thirty-seven-year career in public service. Fort Wayne, Indiana – United States Magistrate Judge Susan L. Judge Collins has served nearly a decade as a Magistrate Judge for the United States District Court for the Northern District of Indiana.
LexBlog IP
SEPTEMBER 27, 2023
The parties will file dispositive motions on June 4, 2025, with responsive and reply briefing complete by July 2, 2025, and July 25, 2025, respectively. The Court further scheduled a five-day jury trial to begin on November 17, 2025. Stay tuned to Big Molecule Watch for more updates on this litigation.
LexBlog IP
MARCH 6, 2024
The agreement allows Biocon to launch in the United States in February 2025, pending FDA approval. entry date for its ustekinumab biosimilar, WEZLANA, of January 1, 2025, and in October 2023, the FDA approved WEZLANA as biosimilar to and interchangeable with STELARA. Amgen secured a U.S.
IP Law 360
NOVEMBER 1, 2023
1, 2025, the firm announced Wednesday. DLA Piper Americas Chair Frank Ryan has been elected to a second four-year term starting Jan.
JD Supra Law
APRIL 4, 2024
On March 26, 2024, the US Patent & Trademark Office (PTO) issued a notice of proposed rulemaking in the Federal Register concerning changes to trademark application filings and fee adjustments in trademark cases for 2025. The PTO solicits written comments from the public on the proposed rule changes on or before May 28, 2024.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content